Revvity Comprehensive Income 2010-2024 | RVTY

Revvity comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
  • Revvity comprehensive income for the quarter ending September 30, 2024 was $-0.232B, a 38.85% decline year-over-year.
  • Revvity comprehensive income for 2023 was $-0.277B, a 38.17% decline from 2022.
  • Revvity comprehensive income for 2022 was $-0.447B, a 175.06% increase from 2021.
  • Revvity comprehensive income for 2021 was $-0.163B, a 409.03% increase from 2020.
Revvity Annual Comprehensive Income
(Millions of US $)
2023 $-277
2022 $-447
2021 $-163
2020 $-32
2019 $-200
2018 $-176
2017 $-47
2016 $-101
2015 $-46
2014 $25
2013 $78
2012 $67
2011 $54
2010 $51
2009 $-27
Revvity Quarterly Comprehensive Income
(Millions of US $)
2024-09-30 $-232
2024-06-30 $-342
2024-03-31 $-325
2023-12-31 $-277
2023-09-30 $-379
2023-06-30 $-305
2023-03-31 $-304
2022-12-31 $-447
2022-09-30 $-650
2022-06-30 $-459
2022-03-31 $-247
2021-12-31 $-163
2021-09-30 $-146
2021-06-30 $-92
2021-03-31 $-104
2020-12-31 $-32
2020-09-30 $-144
2020-06-30 $-217
2020-03-31 $-278
2019-12-31 $-200
2019-09-30 $-243
2019-06-30 $-181
2019-03-31 $-174
2018-12-31 $-176
2018-09-30 $-161
2018-06-30 $-131
2018-03-31 $-28
2017-12-31 $-47
2017-09-30 $-54
2017-06-30 $-63
2017-03-31 $-82
2016-12-31 $-101
2016-09-30 $-55
2016-06-30 $-45
2016-03-31 $-14
2015-12-31 $-46
2015-09-30 $-33
2015-06-30 $13
2015-03-31 $1
2014-12-31 $25
2014-09-30 $48
2014-06-30 $81
2014-03-31 $78
2013-12-31 $78
2013-09-30 $69
2013-06-30 $52
2013-03-31 $53
2012-12-31 $67
2012-09-30 $59
2012-06-30 $38
2012-03-31 $68
2011-12-31 $54
2011-09-30 $-31
2011-06-30 $10
2011-03-31 $-6
2010-12-31 $51
2010-09-30 $-45
2010-06-30 $-98
2010-03-31 $-56
2009-12-31 $-27
2009-09-30 $-16
2009-06-30 $-37
2009-03-31 $-79
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00